miR-579-3p Controls Hepatocellular Carcinoma Formation by Regulating the Phosphoinositide 3-Kinase-Protein Kinase B Pathway in Chronically Inflamed Liver.
Quintavalle C, Meyer-Schaller N, Roessler S, Calabrese D, Marone R, Riedl T, Picco-Rey S, Panagiotou OA, Uzun S, Piscuoglio S, Boldanova T, Bian CB, Semela D, Jochum W, Cathomas G, Mertz KD, Diebold J, Mazzucchelli L, Koelzer VH, Weber A, Decaens T, Terracciano LM, Heikenwalder M, Hoshida Y, Andersen JB, Thorgeirsson SS, Matter MS.
Quintavalle C, et al.
Hepatol Commun. 2022 Jun;6(6):1467-1481. doi: 10.1002/hep4.1894. Epub 2022 Feb 8.
Hepatol Commun. 2022.
PMID: 35132819
Free PMC article.
Comparison of the two cohorts revealed that liver tissue from patients developing HCC displayed a down-regulation of miR-579-3p as an early step in HCC development, which was further confirmed in a validation cohort. ...In vitro experiments and the use of clu …
Comparison of the two cohorts revealed that liver tissue from patients developing HCC displayed a down-regulation of miR-579- …